Presentation of the Centre
Jinshazhou Hospital of Guangzhou University of Chinese Medicine is a non-profit private Grade III general hospital integrating medical treatment, teaching, scientific research and prevention.
Located at No. 1 Lichuan East Street, Jinshazhou, Baiyun District, Guangzhou, Guangdong province in China.
There are 1,500 beds for impatient hospitalisation (800 beds dedicated for Cancer Care), 48 beds for intensive care (ICUs) and 31 operating rooms (among which 5 are Class 100 laminar flow operating rooms and 8 interventional operating rooms). A new building of 500 VIP wards will be in use for this year.
The medical equipment installed in the hospital is consisted by four major platforms: the Precision Detection Platform, the Imaging Diagnosis Platform, the Radiation Therapy Platform and the Comprehensive Cancer Treatment Platform for satisfying to the medical care.
Precision Detection Platform
The hospital offers more than 20 gene testing packages based on Whole Exome Sequencing (WES) and Next-Generation Sequencing (NGS) technologies for tumor companion diagnosis and supplementary diagnosis. The Laboratory is agreed with the ISO 15189 standard and the US College of American Pathologists (CAP) quality standards. There are 6500 specimen executed for the year 2025. The Clinical biological Laboratory can carry out over 2,600 types of testing projects. There are 930254 samples tested during the year 2025.
Imaging Examination Platform
The platform is equipped with more than 20 sets of various imaging devices, including one 4th-generation PET-MR, two PET-CT scanners, five 3.0T MRI scanners, and five 4th-generation dual-source CT scanners. 105840 examinations done during the 2025. All imaging can be used to radiation image fusion for the best delineation of volume target of radiotherapy.
Radiation Therapy Platform
In accordance with international standards, the hospital has established a radiation therapy system and installed advanced radiotherapy equipments including one the Accuray M6 CyberKnife (an artificial intelligence radiosurgery system), one H helical tomotherapy system, three Varian TrueBeam, two Halcyon and one Ethoslinear accelerators, one Gamma Knife treatment system, one Varian HDR/LDR intracavitary brachytherapy systems (afterloading), one Zeiss Intrabeam 600 intraoperative radiotherapy system, one Gamma Knife treatment system. And radioactive particle implantation therapy system, as well as nuclear medicine therapy programs such as yttrium-90 for liver cancer treatment, strontium-89 for bone tumor treatment, and iodine-131 for hyperthyroidism and thyroid cancer treatment. In addition, a proton radiation therapy system is coming soon. There are 10270 cancer patients irradiated for 2025.
Comprehensive Cancer Treatment Platform
This platform is furnished with one the da Vinci surgical robot room and 31 operating rooms (five 100 laminar operating rooms), eight Siemens DSA interventional operating rooms and 2 Philips DSA systems with hybrid operating rooms, the hematological stem cell transplantation chambers, irreversible electroporation (IRE) ablation systems (nanoknife), argon-helium cryoablation systems, high-intensity focused ultrasound (HIFU) systems, sonodynamic and photodynamic therapy systems, and the 6th-generation BSD deep tumor phased array hyperthermia system. 10716 intervention operations performed for the year 2025.
The medical oncology care is the key discipline of the hospital, gathering a dozens of expert teams including the Nuclear Medicine Diagnosis and Treatment Center, Cholelithiasis Center, Blood Purification Center, Orthopaedics Diagnosis and Treatment Center, Minimally Invasive Diagnosis and Treatment Center, Emergency and Critical Care Center, Rehabilitation Center, and Ophthalmology Center as specialized team work. And strongly supported by a group of basic medical cares like cardiology, pneumology, enterogastrology, nephrology and the surgery departments like neurological, thoracic, digestive, urological gynaecological surgery and the Chinese medicine department.
The hospital received 682769 outpatient consultations (138867 cancer patients), 42819 full hospitalisations (21154 cancer patients), 9756 news cancer patients.
The hospital is open to satisfy the medical needs for the patients not only coming from the local region, but all of the patients coming from others provinces, other country of Asia, Africa and Europe. 80% patients come from other regions outside of Guangzhou city.